Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery

Kopriva Marshall, Michael D. Chan, Thomas P. McCoy, Adam C. Aubuchon, J. Daniel Bourland, Kevin P. McMullen, Allan F. deGuzman, Michael T. Munley, Edward G. Shaw, Stephen B. Tatter, Thomas L. Ellis

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Gamma Knife Radiosurgery (GKRS) has been reported as an effective modality to treat trigeminal neuralgia (TN). OBJECTIVE: To determine predictive factors for the successful treatment of trigeminal neuralgia with GKRS. METHODS: Between 1999 and 2008, 777 GKRS procedures for patients with TN were performed at our institution. Evaluable follow-up data were obtained for 448 patients. Median follow-up time was 20.9 months (3-86 months). The mean maximum prescribed dose was 88 Gy (80-97 Gy). Dosimetric variables recorded included dorsal root entry zone dose (DREZ), pons maximum dose, dose to the petrous dural ridge, and the cisternal nerve length. RESULTS: 86% of patients achieved BNI I-III pain scores by 3 months after GKRS, with 43% of patients achieving a BNI I pain score. 26% of patients reported post-treatment facial numbness. 28% of patients reported a post-GKRS procedure for relapsed pain and median time to next procedure was 4.4 years. Multivariate analysis revealed that the development of post-surgical numbness (OR 2.76, p=0.006) was the dominant factor predictive of efficacy. Longer cisternal nerve length (OR 0.85, p=0.005), prior radiofrequency ablation (OR 0.35, p=0.028), and diabetes (OR 0.38, p=0.013) predicted decreased efficacy. The mean dose delivered to the DREZ in patients who developed facial numbness (57.6 Gy) was more than the mean dose (47.3 Gy) to patients who did not develop numbness (p=0.02). CONCLUSION: The development of post-GKRS facial numbness is a dominant factor that predicts for efficacy of GKRS. History of diabetes or previous RFA may portend worsened outcome.

Original languageEnglish
JournalNeurosurgery
DOIs
StateAccepted/In press - Aug 12 2011
Externally publishedYes

Fingerprint

Trigeminal Neuralgia
Radiosurgery
Hypesthesia
Spinal Nerve Roots
Therapeutics
Pain
Pons
Multivariate Analysis

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Cite this

Marshall, K., Chan, M. D., McCoy, T. P., Aubuchon, A. C., Bourland, J. D., McMullen, K. P., ... Ellis, T. L. (Accepted/In press). Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery. Neurosurgery. https://doi.org/10.1227/NEU.0b013e3182320d36

Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery. / Marshall, Kopriva; Chan, Michael D.; McCoy, Thomas P.; Aubuchon, Adam C.; Bourland, J. Daniel; McMullen, Kevin P.; deGuzman, Allan F.; Munley, Michael T.; Shaw, Edward G.; Tatter, Stephen B.; Ellis, Thomas L.

In: Neurosurgery, 12.08.2011.

Research output: Contribution to journalArticle

Marshall, K, Chan, MD, McCoy, TP, Aubuchon, AC, Bourland, JD, McMullen, KP, deGuzman, AF, Munley, MT, Shaw, EG, Tatter, SB & Ellis, TL 2011, 'Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery', Neurosurgery. https://doi.org/10.1227/NEU.0b013e3182320d36
Marshall, Kopriva ; Chan, Michael D. ; McCoy, Thomas P. ; Aubuchon, Adam C. ; Bourland, J. Daniel ; McMullen, Kevin P. ; deGuzman, Allan F. ; Munley, Michael T. ; Shaw, Edward G. ; Tatter, Stephen B. ; Ellis, Thomas L. / Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery. In: Neurosurgery. 2011.
@article{457734013f614d168a29788c2be02284,
title = "Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery",
abstract = "BACKGROUND: Gamma Knife Radiosurgery (GKRS) has been reported as an effective modality to treat trigeminal neuralgia (TN). OBJECTIVE: To determine predictive factors for the successful treatment of trigeminal neuralgia with GKRS. METHODS: Between 1999 and 2008, 777 GKRS procedures for patients with TN were performed at our institution. Evaluable follow-up data were obtained for 448 patients. Median follow-up time was 20.9 months (3-86 months). The mean maximum prescribed dose was 88 Gy (80-97 Gy). Dosimetric variables recorded included dorsal root entry zone dose (DREZ), pons maximum dose, dose to the petrous dural ridge, and the cisternal nerve length. RESULTS: 86{\%} of patients achieved BNI I-III pain scores by 3 months after GKRS, with 43{\%} of patients achieving a BNI I pain score. 26{\%} of patients reported post-treatment facial numbness. 28{\%} of patients reported a post-GKRS procedure for relapsed pain and median time to next procedure was 4.4 years. Multivariate analysis revealed that the development of post-surgical numbness (OR 2.76, p=0.006) was the dominant factor predictive of efficacy. Longer cisternal nerve length (OR 0.85, p=0.005), prior radiofrequency ablation (OR 0.35, p=0.028), and diabetes (OR 0.38, p=0.013) predicted decreased efficacy. The mean dose delivered to the DREZ in patients who developed facial numbness (57.6 Gy) was more than the mean dose (47.3 Gy) to patients who did not develop numbness (p=0.02). CONCLUSION: The development of post-GKRS facial numbness is a dominant factor that predicts for efficacy of GKRS. History of diabetes or previous RFA may portend worsened outcome.",
author = "Kopriva Marshall and Chan, {Michael D.} and McCoy, {Thomas P.} and Aubuchon, {Adam C.} and Bourland, {J. Daniel} and McMullen, {Kevin P.} and deGuzman, {Allan F.} and Munley, {Michael T.} and Shaw, {Edward G.} and Tatter, {Stephen B.} and Ellis, {Thomas L.}",
year = "2011",
month = "8",
day = "12",
doi = "10.1227/NEU.0b013e3182320d36",
language = "English",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Predictive variables for the successful treatment of trigeminal neuralgia with gamma knife™ radiosurgery

AU - Marshall, Kopriva

AU - Chan, Michael D.

AU - McCoy, Thomas P.

AU - Aubuchon, Adam C.

AU - Bourland, J. Daniel

AU - McMullen, Kevin P.

AU - deGuzman, Allan F.

AU - Munley, Michael T.

AU - Shaw, Edward G.

AU - Tatter, Stephen B.

AU - Ellis, Thomas L.

PY - 2011/8/12

Y1 - 2011/8/12

N2 - BACKGROUND: Gamma Knife Radiosurgery (GKRS) has been reported as an effective modality to treat trigeminal neuralgia (TN). OBJECTIVE: To determine predictive factors for the successful treatment of trigeminal neuralgia with GKRS. METHODS: Between 1999 and 2008, 777 GKRS procedures for patients with TN were performed at our institution. Evaluable follow-up data were obtained for 448 patients. Median follow-up time was 20.9 months (3-86 months). The mean maximum prescribed dose was 88 Gy (80-97 Gy). Dosimetric variables recorded included dorsal root entry zone dose (DREZ), pons maximum dose, dose to the petrous dural ridge, and the cisternal nerve length. RESULTS: 86% of patients achieved BNI I-III pain scores by 3 months after GKRS, with 43% of patients achieving a BNI I pain score. 26% of patients reported post-treatment facial numbness. 28% of patients reported a post-GKRS procedure for relapsed pain and median time to next procedure was 4.4 years. Multivariate analysis revealed that the development of post-surgical numbness (OR 2.76, p=0.006) was the dominant factor predictive of efficacy. Longer cisternal nerve length (OR 0.85, p=0.005), prior radiofrequency ablation (OR 0.35, p=0.028), and diabetes (OR 0.38, p=0.013) predicted decreased efficacy. The mean dose delivered to the DREZ in patients who developed facial numbness (57.6 Gy) was more than the mean dose (47.3 Gy) to patients who did not develop numbness (p=0.02). CONCLUSION: The development of post-GKRS facial numbness is a dominant factor that predicts for efficacy of GKRS. History of diabetes or previous RFA may portend worsened outcome.

AB - BACKGROUND: Gamma Knife Radiosurgery (GKRS) has been reported as an effective modality to treat trigeminal neuralgia (TN). OBJECTIVE: To determine predictive factors for the successful treatment of trigeminal neuralgia with GKRS. METHODS: Between 1999 and 2008, 777 GKRS procedures for patients with TN were performed at our institution. Evaluable follow-up data were obtained for 448 patients. Median follow-up time was 20.9 months (3-86 months). The mean maximum prescribed dose was 88 Gy (80-97 Gy). Dosimetric variables recorded included dorsal root entry zone dose (DREZ), pons maximum dose, dose to the petrous dural ridge, and the cisternal nerve length. RESULTS: 86% of patients achieved BNI I-III pain scores by 3 months after GKRS, with 43% of patients achieving a BNI I pain score. 26% of patients reported post-treatment facial numbness. 28% of patients reported a post-GKRS procedure for relapsed pain and median time to next procedure was 4.4 years. Multivariate analysis revealed that the development of post-surgical numbness (OR 2.76, p=0.006) was the dominant factor predictive of efficacy. Longer cisternal nerve length (OR 0.85, p=0.005), prior radiofrequency ablation (OR 0.35, p=0.028), and diabetes (OR 0.38, p=0.013) predicted decreased efficacy. The mean dose delivered to the DREZ in patients who developed facial numbness (57.6 Gy) was more than the mean dose (47.3 Gy) to patients who did not develop numbness (p=0.02). CONCLUSION: The development of post-GKRS facial numbness is a dominant factor that predicts for efficacy of GKRS. History of diabetes or previous RFA may portend worsened outcome.

UR - http://www.scopus.com/inward/record.url?scp=80051602837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051602837&partnerID=8YFLogxK

U2 - 10.1227/NEU.0b013e3182320d36

DO - 10.1227/NEU.0b013e3182320d36

M3 - Article

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

ER -